PFF Summit 2013 Patient/Caregiver Sessions

Patient and Caregiver Sessions

Friday > Sessions

Welcome and Introduction, Daniel M. Rose, MD, CEO and Chairman of the Board, Pulmonary Fibrosis Foundation | VIEW SLIDES  | WATCH WEBINAR

Opening Session Keynote Address, Cystic Fibrosis Therapeutic Development: A Game Changer,  Robert J. Beall, PhD, President and CEO and Chairman of the Board, Cystic Fibrosis Foundation |VIEW SLIDES

What is Pulmonary Fibrosis (PF), What are the Causes, and How is it Treated?, Harold R. Collard, MD  | VIEW SLIDES | WATCH WEBINAR

What is Autoimmune Related Pulmonary Fibrosis?, Richard T. Meehan, MD  | VIEW SLIDES | WATCH WEBINAR

What is Pulmonary Hypertension and How is it Related to PF?, Steven Kawut, MD, MS  |VIEW SLIDES| WATCH WEBINAR

Special Luncheon Speaker: When Drug Research is Personal: The Importance of Patient Advocacy in Drug Development and Innovation, John F. Crowley, JD, MBA, Chairman and CEO, Amicus Therapeutics | VIEW SLIDES | VIEW WEBINAR

Occupational and Environmental Related Pulmonary Fibrosis, Cecile S. Rose, MD, MPH  | VIEW SLIDES | WATCH WEBINAR

Saturday > Sessions

Research Trials, Stem Cell Therapies, and the Drug Pipeline, Erica L. Herzog, MD  | VIEW SLIDES | WATCH WEBINAR

Lung Transplantation and PF, Errol L. Bush, MD  | VIEW SLIDES | WATCH WEBINAR

The Final Stages of Pulmonary Disease, Molly Bourne, MD  | VIEW SLIDES | WATCH WEBINAR

Tools for Living Better with Pulmonary Fibrosis, Susan S. Jacobs, RN, MS  | VIEW SLIDES | WATCH WEBINAR

Effective Advocacy for Pulmonary Fibrosis, Brian Baird, MS, PhD  | VIEW SLIDES | WATCH WEBINAR

The Role of the FDA in the Process of Drug Development, Eugene J. Sullivan, MD  | VIEW SLIDES | WATCH WEBINAR

US Food and Drug Administration -- Patient-Focused Drug Development Program, Richard M. Klein  | VIEW SLIDES | WATCH WEBINAR

Meet the Experts–Q+A Roundtable Discussions

caregiversessions6

 

 

caregiversessions1

 

 

caregiversessions4